Uncategorized

GLP-1 medications reduced the risk of major adverse cardiovascular events by 13% compared to a placebo, according to a study published Nov. 25 in The Lancet Diabetes & Endocrinology.

An Atlanta-based Emory University Hospital team became the first in the U.S. to perform a surgical implantation of magnetically levitated ventricular assist device.

Patients were 20.29% more likely to complete colorectal cancer screening through at-home testing compared to standard care, according to a study published Nov. 25 in JAMA Network Open. 

Cleveland Clinic's VeloSano Cancer Research Accelerator Fund raised $29 million in 2024, the most raised annually since the fund's inception.

Charlottesville, Va.-based UVA Cancer Center has partnered with the Appalachian Community Cancer Alliance and Grundy, Va.-based Buchanan General Hospital to bring lung cancer screening to rural Virginia and West Virginia residents. 

Ninety-five percent of CPR training manikins on the global market are flat-chested, possibly contributing to disproportionate survival outcomes for women after cardiac arrest, according to a study published Nov. 21 in Health Promotional International. 

Healthgrades published its 2025 Specialty Excellence Awards recipients Oct. 22. Of those, 97 hospitals were recognized for delivering superior clinical outcomes in cardiac care for heart bypass surgery, coronary interventional procedures, heart attack treatment, heart failure treatment and heart valve…

Although lung cancer incidence rates are declining, more young and middle-age women are being diagnosed at higher rates than men, CNN reported Nov. 25. 

Memorial Hospital at Gulfport (Miss.) reported the highest Medicare payment of $38,459 for heart attack care between July 1, 2020, and June 30, 2023, according to CMS data published Oct. 30. 

There have been 11 cancer-related novel drug approvals in 2024, according to the FDA website.